Welcome to the international HTA database

Showing [23886 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2023	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Restless legs syndrome: can the symptoms be alleviated through non-medicinal procedures?]
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Radiofrequency ablation of parathyroid glands]
2023	Institute for Clinical and Economic Review (ICER)	Applying the results of comparative effectiveness research to control drug costs: policy options for California
2023	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Contraception: comparison of hormonal coils and copper coils]
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Levonorgestrel-releasing intrauterine device as contraceptive method in women of childbearing age]
2023	Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS)	[Support for the implementation of new ways of working at the Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale]
2023	Norwegian Institute of Public Health (NIPH)	177Lu-PSMA-617 for treatment of metastatic castration resistant prostate cancer: a health technology assessment
2023	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Evaluation of the lung cancer screening program]
2023	Institute for Clinical and Economic Review (ICER)	Advancing health technology assessment methods that support health equity
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Cannabidiol in epilepsy. National versus international products comparison]
2023	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Ovarian tissue cryopreservation and transplantation in patients with cancer or benign diseases to fertility preservation]
2023	Institute for Clinical and Economic Review (ICER)	Assessment of barriers to fair access
2023	National Evidence-based Healthcare Collaborating Agency (NECA)	[Low-level light therapy for primary dysmenorrhea]
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[CROS and BICROS hearing aids in unilateral and asymmetric bilateral hearing loss]
2023	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Efficacy and safety of Emotional Freedom Techniques for the treatment of anxiety, depression and post traumatic stress disorders]
2023	Penn Medicine Center for Evidence-based Practice (CEP)	Effectiveness of communication strategies for patients who are non-vocal due to artificial airways
2023	Health Technology Wales (HTW)	Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failure
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Medial pivot prosthesis in primary total knee arthroplasty]
2023	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Invasive monitoring of pulmonary artery pressure in patients with symptomatic heart failure]
2023	Health Information and Quality Authority (HIQA)	Rapid health technology assessment of continuous glucose monitoring in adults with type 1 diabetes mellitus
2023	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Robotic surgery in benign and malignant surgical pathology (urology, general and digestive surgery, cardiothoracic surgery, gynecology, endocrinology, ophthalmology, and head and neck surgery). Chapter I: cardiothoracic, endocrine, ophthalmological surgery, and head and neck surgery]
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Multiplex PCR for moderate to severe acute lower respiratory tract infections]
2023	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Concept for routine practice data collection acc. to the Law for More Safety in the Supply of Medicines (GSAV) – exagamglogene autotemcel (sickle cell disease)]
2023	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Early detection tools for emotional distress in adult people with cancer]
2023	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Robotic surgery in benign and malignant surgical pathology (urology, general and digestive surgery, cardiothoracic surgery, gynecology, endocrinology, ophthalmology, and head and neck surgery). Chapter II: urological, gynecological, general and digestive surgery]
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Deep brain stimulation for dystonia refractory to medical treatment]
2023	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Spinal cord stimulation in refractory neuropathic pain in adults: evaluation of efficacy, effectiveness, safety, and efficiency in painful diabetic neuropathy and failed back surgery and complex regional pain syndromes]
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Use of biomaterials in tympanoplasty for tympanic membrane repair]
2023	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Evaluation of the safety, diagnostic validity, and clinical effectiveness of transcutaneous measurement of partial pressure of oxygen in the management of diabetic foot]
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[FONAKIDs® multimodal approach in congenital or acquired apraxia of speech]
2023	NIHR Health Technology Assessment programme	Antibiotics for lower respiratory tract infection in children presenting in primary care: ARTIC PC RCT
2023	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Evaluation of early intervention programs in psychosis for adolescents and young adults]
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Nivolumab plus ipilimumab in pleural mesothelioma]
2023	Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS)	Assessment of hip protectors for users at risk of falls
2023	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Artificial intelligence for the detection of colorectal precancerous lesions in colonoscopy]
2023	Andalusian Health Technology Assessment Area (AETSA)	[Appropiate indication for leadless pacemaker. Systematic review and appropriateness criteria]
2023	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Blood test for the identification and location of different types of cancer]
2023	The Regional Health Technology Assessment Centre (HTA-centrum)	General psychiatric management for patients with personality disorder and/or self-harm behaviour
2023	NIHR Health Technology Assessment programme	Evaluation of the Healthy Start Voucher Scheme in UK: a natural experiment using the Growing Up in Scotland record linkage study and the Infant Feeding Survey
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guides and standards: update of the tool for choosing the dosage of monoclonal antibodies targeting PD 1 or PD-L1]
2023	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Safety, efficacy, and economic evaluation of the implementation of an abdominal aortic aneurysm screening program]
2023	The Regional Health Technology Assessment Centre (HTA-centrum)	Efficacy and safety of advanced hybrid closed loop systems compared with multiple daily injections or open loop systems, in adults with type 1 diabetes
2023	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Birch Bark Extract (treatment of wounds associated with epidermolysis bullosa (6 months and older))]
2023	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[PCR type nucleic acid amplification tests in blood applied to rapid etiological diagnosis in suspected sepsis: assessment of its diagnostic and prognostic utility, safety, and economic and organizational implementation considerations]
2023	Canadian Agency for Drugs and Technologies in Health (CADTH)	Treatment of adult patients with chronic immune thrombocytopenia after failure of first-line therapies
2023	The Federal Joint Committee (G-BA)	[Pharmaceutical Directive/Annex XII: Efgartigimod alfa (Myasthenia Gravis, AChR-antibody+)]
2023	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Remote monitoring of lung function through self-administered spirometry in patients with asthma, chronic obstructive pulmonary disease or cystic fibrosis: evaluation of safety, clinical efficacy and implementation aspects]
2023	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Peripheral electrical nerve stimulation (PENS) therapy as treatment for refractory chronic neuropathic pain in adults: evaluation of safety, efficacy, clinical effectiveness, and cost-effectiveness]
2023	The Regional Health Technology Assessment Centre (HTA-centrum)	[Remote patient monitoring– an overview of systematic reviews for selected diagnosis groups]
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: assessment of the relevance of tandem mass spectrometry-based newborn blood spot screening for glutaric acidemia type 1 (GA1)]
2023	Health Technology Wales (HTW)	Solution-focused assessment tools for improving the treatment of people with psychosis and schizophrenia within secondary mental health services
2023	The Regional Health Technology Assessment Centre (HTA-centrum)	[Remote patient monitoring– an overview of systematic reviews for selected diagnosis groups]
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: assessment of the relevance of tandem mass spectrometry-based newborn blood spot screening for for long-chain acyl-CoA dehydrogenase deficiency (LCHADD) and mitochondrial trifunctional protein deficiency (TFPD)]
2023	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Health technology assessment framework: adaptation for digital health technology assessment]
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: assessment of the relevance of tandem mass spectrometry-based newborn blood spot screening for very long-chain acyl-CoA dehydrogenase deficiency (VLCADD)]
2023	NIHR Health and Social Care Delivery Program	Rapid evaluation of service innovations in health and social care: key considerations
2023	Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU)	[Update: Functioning and disability - An evidence map]
2023	NIHR Health Services and Delivery Research programme	A rapid mixed-methods evaluation of remote home monitoring models during the COVID-19 pandemic in England
2023	NIHR Health Services and Delivery Research programme	What happens after an NHS Health Check? A survey and realist review
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Non-invasive monitoring of intracranial compliance and intracranial pressure in central nervous system lesions]
2023	NIHR Health Services and Delivery Research programme	Identifying models of care to improve outcomes for older people with urgent care needs: a mixed methods approach to develop a system dynamics model
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Angioplasty and stenting in patients with carotid artery stenosis]
2023	Austrian Institute for Health Technology Assessment (AIHTA)	Biomarkers in Alzheimer's disease
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Lecanemab in Alzheimer’s Disease]
2023	NIHR Health Services and Delivery Research programme	Explanation of context, mechanisms and outcomes in adult community mental health crisis care: the MH-CREST realist evidence synthesis
2023	Belgian Health Care Knowledge Centre (KCE)	Silicone adhesive multilayer foam dressings to prevent hospital-acquired pressure ulcers: a Belgian RCT-based economic evaluation
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Mobile cardiopulmonary exercise test in athletes or cardiopulmonary rehabilitation]
2023	NIHR Health Services and Delivery Research programme	Integration, effectiveness and costs of different models of primary health care provision for people who are homeless: an evaluation study
2023	Norwegian Institute of Public Health (NIPH)	Treatments for relapsing and/or refractory multiple myeloma. A health technology assessment
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Lipogems® System for autologous adipose tissue-derived mesenchymal stem cells transfer in orthopedic conditions]
2023	NIHR Health Services and Delivery Research programme	Vertical integration of general practices with acute hospitals in England: rapid impact evaluation
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: use of platelet-rich plasma for the treatment of knee osteoarthritis]
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Holmium laser in non-prostate endourologic conditions]
2023	NIHR Health Technology Assessment programme	Frenotomy with breastfeeding support versus breastfeeding support alone for infants with tongue-tie and breastfeeding difficulties: the FROSTTIE RCT
2023	NIHR Health Technology Assessment programme	Integration, effectiveness and costs of different models of primary health care provision for people who are homeless: an evaluation study
2023	NIHR Health Technology Assessment programme	Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Sapropterin in patients with phenylketonuria]
2023	NIHR Health Technology Assessment programme	A randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery for open globe trauma – the ASCOT study
2023	NIHR Health Technology Assessment programme	Total ankle replacement versus ankle arthrodesis for patients aged 50–85 years with end-stage ankle osteoarthritis: the TARVA RCT
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Combination diagnostic tests offered as part of preventive health checks exams in overall population]
2023	NIHR Health Technology Assessment programme	Helping pregnant smokers quit: a multi-centre randomised controlled trial of electronic cigarettes versus nicotine replacement therapy
2023	Haute Autorite de sante (HAS)	[Comparative genomic hybridization array (CGHA) analysis in postnatal context]
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Polymeric diet rich in TGF-β for inflammatory bowel disease in pediatric patients]
2023	NIHR Health Technology Assessment programme	Cost-effectiveness of therapeutics for COVID-19 patients: a rapid review and economic analysis
2023	National Authority for Assessment and Accreditation in Healthcare (INEAS)	[Kadcyla® (trastuzumab emtansine) in the treatment of HER2-positive breast cancer : A rapid review]
2023	NIHR Public Health Research (PHR) programme	A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Triple-phase computed tomography in patients with liver lesion]
2023	NIHR Health Technology Assessment programme	Antidepressants in pregnancy: applying causal epidemiological methods to understand service-use outcomes in women and long-term neurodevelopmental outcomes in exposed children
2023	National Authority for Assessment and Accreditation in Healthcare (INEAS)	[Autologous adipose-derived stem cells for chronic wounds treatment : Full HTA report]
2023	NIHR Public Health Research (PHR) programme	Impact of a social prescribing intervention in North East England on adults with type 2 diabetes: the SPRING_NE multimethod study
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Dielectric radiofrequency for the treatment of primary hyperhidrosis and bromhidrosis]
2023	NIHR Health Technology Assessment programme	Insights from UKCTOCS for design, conduct and analyses of large randomised controlled trials
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Transbronchial biopsy guided by endobronchial ultrasound (EBUS) in pathologies accesible by transbronchial puncture that required anatomopathological diagnosis]
2023	NIHR Health Services and Delivery Research programme	Understanding what affects psychological morbidity in informal carers when providing care at home for patients at the end of life: a systematic qualitative evidence synthesis
2023	The Danish Health Technology Council (DHTC)	[Assessment concerning glucose monitoring for the treatment of adult patients with type 1 diabetes]
2023	Institute for Clinical Effectiveness and Health Policy (IECS)	[Invasive electroencephalography for drug-resistant epilepsy]
2023	NIHR Health Technology Assessment programme	Extracorporeal carbon dioxide removal compared to ventilation alone in patients with acute hypoxaemic respiratory failure: cost-utility analysis of the REST RCT
2023	Norwegian Institute of Public Health (NIPH)	[Brace compression for treatment of pectus carinatum: a rapid health technology assessment]
2023	Institut national d'excellence en sante et en services sociaux (INESSS)	[Guides and standards: the management of myalgic encephalomyelitis / chronic fatigue syndrome]
2023	Austrian Institute for Health Technology Assessment (AIHTA)	Robot-assisted surgery in thoracic and visceral indications – Update 2023